Cassava Sciences Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Good afternoon. My name is Daniil Gataulin. I'm a senior biotech associate at Raymond James. Our next presenter is Remi Barbier, President and CEO of Cassava Sciences; and Eric Schoen, Chief Financial Officer.
Cassava Sciences is a clinical stage biotechnology company focused on the detection and treatment of neurodegenerative diseases, such as Alzheimer's disease. Remi and Eric, welcome. The floor is yours.
Thank you for that kind introduction, and thank you, Raymond James, for inviting us to your biotech conference. And I hope that one of these quarters or years, we get to meet actually in person instead of virtually. With that, what I would propose to do is run through our presentation -- it will take about 30 minutes -- and see where we go from there.
So yes, we are Cassava Sciences. I am Remi Barbier, President and CEO. Before we actually begin, we have a number of forward-looking statements and safe
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
